Biotech

• 9/30/2024

  **INmune Bio’s INKmune: A New Approach for mCRPC Treatment**

• 9/29/2024

  **2 High-Risk, High-Reward Stocks to Buy**

• 9/29/2024

  **Beam Therapeutics: Overvalued and Not a Buy**

• 9/29/2024

  **Amicus Therapeutics Makes Progress**

• 9/25/2024

  **EYLEA Patent Dispute: Impact on Regeneron Investors**

• 9/25/2024

  **Zai Lab’s Path to Profitability by 2025**